chr6-7373173-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001170692.2(CAGE1):āc.1646A>Gā(p.Gln549Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000886 in 1,613,842 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001170692.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CAGE1 | NM_001170692.2 | c.1646A>G | p.Gln549Arg | missense_variant | 5/14 | ENST00000502583.6 | NP_001164163.1 | |
CAGE1 | NM_001170693.2 | c.1646A>G | p.Gln549Arg | missense_variant | 5/13 | NP_001164164.1 | ||
CAGE1 | NM_205864.3 | c.1238A>G | p.Gln413Arg | missense_variant | 4/11 | NP_995586.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CAGE1 | ENST00000502583.6 | c.1646A>G | p.Gln549Arg | missense_variant | 5/14 | 5 | NM_001170692.2 | ENSP00000425493.1 | ||
CAGE1 | ENST00000338150.8 | c.1646A>G | p.Gln549Arg | missense_variant | 5/13 | 2 | ENSP00000338107.4 | |||
CAGE1 | ENST00000379918.8 | c.1646A>G | p.Gln549Arg | missense_variant | 5/14 | 5 | ENSP00000369250.4 | |||
CAGE1 | ENST00000512086.5 | c.1646A>G | p.Gln549Arg | missense_variant | 5/12 | 5 | ENSP00000427583.1 | |||
CAGE1 | ENST00000296742.11 | c.1238A>G | p.Gln413Arg | missense_variant | 4/11 | 1 | ENSP00000296742.7 | |||
CAGE1 | ENST00000442019.6 | n.*912A>G | non_coding_transcript_exon_variant | 5/14 | 1 | ENSP00000391746.2 | ||||
CAGE1 | ENST00000458291.6 | n.1646A>G | non_coding_transcript_exon_variant | 5/14 | 1 | ENSP00000390644.2 | ||||
CAGE1 | ENST00000442019.6 | n.*912A>G | 3_prime_UTR_variant | 5/14 | 1 | ENSP00000391746.2 | ||||
CAGE1 | ENST00000512691.1 | c.*8A>G | downstream_gene_variant | 5 | ENSP00000423789.1 |
Frequencies
GnomAD3 genomes AF: 0.000151 AC: 23AN: 152224Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000145 AC: 36AN: 248678Hom.: 0 AF XY: 0.000111 AC XY: 15AN XY: 134922
GnomAD4 exome AF: 0.0000814 AC: 119AN: 1461500Hom.: 0 Cov.: 33 AF XY: 0.0000922 AC XY: 67AN XY: 727038
GnomAD4 genome AF: 0.000158 AC: 24AN: 152342Hom.: 0 Cov.: 33 AF XY: 0.000188 AC XY: 14AN XY: 74502
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 21, 2023 | The c.1646A>G (p.Q549R) alteration is located in exon 5 (coding exon 4) of the CAGE1 gene. This alteration results from a A to G substitution at nucleotide position 1646, causing the glutamine (Q) at amino acid position 549 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at